Research, including recent findings from the SELECT trial, indicates that GLP-1 agonists like semaglutide can significantly reduce the risk of major cardiovascular events, such as heart attacks and strokes, especially in individuals with obesity but without diabetes
The GLP-1 program is approved by the Food and Drug Administration (FDA) and is recognized as safe for weight management under the supervision of a medical professional.* Why Should You Purchase the GLP-1 program at Doctor Tony Clinic
If it is determined that the treatment isnt appropriate for you after your assessment, your purchase may be refunded
Final Thoughts The conversation around GLP-1 vs traditional weight loss methods marks a shift in how we understand metabolism
Rotate injection sites: To prevent tissue irritation, researchers may vary the injection locations, typically including the thigh, upper arm, and abdomen
They show promise in immunomodulation, regeneration, drug delivery, and aesthetics